Elena Pistocchini
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Exploring AI and ML in managing overlap between cardiovascular disease and asthma or COPD: a scoping review.
Journal: Respiratory medicine
Published: January 07, 2026
Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside.
Journal: Journal of inflammation research
Published: October 02, 2025
Effects of Inhaled β2-AR Agonists in Athletes According to the WADA 2025 List: New Insights From a Systematic Review and Meta-Analysis.
Journal: Scandinavian journal of medicine & science in sports
Published: July 24, 2025
Pharmacological Advances in Managing Exercise-Induced Bronchospasm: An Umbrella Review Following PRIOR Guideline.
Journal: Scandinavian journal of medicine & science in sports
Published: July 14, 2025
Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developments.
Journal: Expert opinion on drug discovery
Published: April 14, 2025
Exploring the role of sex in asthma and COPD pharmacological treatment.
Journal: Current research in pharmacology and drug discovery
Published: March 30, 2025
Corrigendum to "Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat" [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342].
Journal: Pulmonary pharmacology & therapeutics
Published: December 20, 2024
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging.
Journal: Respiratory medicine
Published: November 22, 2024
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat.
Journal: Pulmonary pharmacology & therapeutics
Published: October 21, 2024
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement.
Journal: Expert opinion on pharmacotherapy
Published: June 12, 2024
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval.
Journal: Expert opinion on investigational drugs
Published: June 26, 2023
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol.
Journal: Pulmonary pharmacology & therapeutics
Published: May 08, 2023
Last Updated: 09/26/2026